| Application no. and date | 13754329.4 (espacenet) (Federated) (European Patent Register), 20130228 | | Patent/reg. no. and date | DK/EP 2820013, 20180711 | | Publication date | 20150107 | | Priority no. and date | US 201261606160 P, 20120302 | | EP pub. no. and date |
EP 2820013 20150107 | | Effective date | | | Applicant/owner | Ralexar Therapeutics, Inc., 101 Lindenwood Drive, Suite 400
Malvern, PA 19355, US | | Applicant ref. no. | P168580.DK.01//KERRS/LJUNGBERGR | | Inventor | MOHAN, Raju, 3125 Caminito Ricardo
Encinitas
California 92024, US | | Representative | MURGITROYD & COMPANY, Mannerheimvägen 12B, 5tr
FI-00100 Helsingfors, FI | | Opponent | | | IPC Class | A61K 31/4155 (2006.01) , A61K 31/4245 (2006.01) , A61K 31/433 (2006.01) , A61P 17/00 (2006.01) , C07D 413/04 (2006.01) , C07D 417/04 (2006.01) | | Title | Lever-X-receptor (LXR)-modulatorer til behandling af dermale sygdomme, forstyrrelser og tilstande | | Int. application no. | US2013028438 | | Int. publication no. | WO2013130892 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
